SCHEMBL6595043

SCHEMBL6595043

COc1ccccc1CN(C)C(=O)C(Cc1ccc2ccccc2c1)NC(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTSB P07858 1/20 0.55
CTSS P25774 1/20 0.55
CTSK P43235 1/20 0.55
PTPN1 P18031 1/20 0.53
NPC1 O15118 1/20 0.48
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
ITGA4 P13612 1/20 0.46
ITGB7 P26010 1/20 0.46
CACNA1B Q00975 2/20 0.45
TACR1 P25103 8/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595039 1.00 CTSB (0.55) CTSBCTSSCTSKPTPN1NPC1
SCHEMBL7881440 0.88 PTPN1 (0.66) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL5552762 0.86 CTSS (0.64) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL6589174 0.86 CTSS (0.64) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL27390066 0.86 ITGA4 (0.45) CTSBCTSSCTSKPTPN1NPC1
SCHEMBL7880090 0.86 CTSS (0.58) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL29436793 0.82 CTSS (0.63) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL22255804 0.82 CTSS (0.63) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL5993911 0.82 CTSS (0.63) CTSBCTSSCTSKPTPN1MMP9
SCHEMBL6590570 0.82 CTSB (0.56) CTSBCTSSCTSKPTPN1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0830347-B1 NOVEL SUBSTITUTED PIPERAZINE DERIVATIVES HAVING TACHYKININ RECEPTOR ANTAGONISTS ACTIVITY AVENTIS PHARMA INC (US) 2004-09-22 EP disclosed
CN-1098255-C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity AVENTIS PHARMA INC (US) 2003-01-08 CN disclosed
CN-1083429-C Substituted alkyldiamine derivatives and their use as tachykinin antagonists MERRELL PHARMA INC (US) 2002-04-24 CN disclosed
EP-0767783-B1 SUBSTITUTED ALKYLDIAMINE DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERRELL PHARMA INC (US) 1998-08-19 EP disclosed
CN-1181753-A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity HOECHST MARION ROUSSEL INC (US) 1998-05-13 CN disclosed
EP-0830347-A1 NOVEL SUBSTITUTED PIPERAZINE DERIVATIVES HAVING TACHYKININ RECEPTOR ANTAGONISTS ACTIVITY HOECHST MARION ROUSSEL, INC. (US) 1998-03-25 EP disclosed
CN-1155883-A Substituted alkyldiamine derivatives and their use as tachykinin antagonists MERRELL PHARMA INC (US) 1997-07-30 CN disclosed
EP-0767783-A1 SUBSTITUTED ALKYLDIAMINE DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1997-04-16 EP disclosed
US-5597845-A TACHYKININ ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1997-01-28 US disclosed
WO-1996032385-A1 NOVEL SUBSTITUTED PIPERAZINE DERIVATIVES HAVING TACHYKININ RECEPTOR ANTAGONISTS ACTIVITY HOECHST MARION ROUSSEL, INC. (US) 1996-10-17 WO disclosed
WO-1995035279-A1 SUBSTITUTED ALKYLDIAMINE DERIVATIVES AND THEIR USE AS TACHYKININ ANTAGONISTS MERRELL PHARMACEUTICALS INC. (US) 1995-12-28 WO disclosed